Clinical Manifestations Vary with Different Age Spectrums in Infants with Kawasaki Disease

Table 2

Laboratory results.

Variable	Group 1 (𝑛=30)	Group  2 (𝑛=35)	Group  3 (𝑛=80)	𝑃 value
				Group  1; versus group 2	Group  1; versus group 3	Group  2; versus group 3
WBC, mean ± SD, (/cumm)	19810.0±10880.3	17242.9±5830.0	13653.1±4826.1	0.127	<0.001^†	0.009^†
Hemoglobin, mean ± SD, (g/dL)	9.9±1.2	10.7±1.6	11.0±1.2	0.015^†	<0.001^†	0.199
Platelet, mean ± SD, (/cumm)	492966.7±163522.1	397200.0±140359.0	355337.5±132276.4	0.007^†	<0.001^†	0.145
CRP, mean ± SD, (mg/dL)	11.0±7.1	9.4±5.9	9.8±6.9	NS
Aspartate aminotransferase, mediam (range), (units/L)	37 (12~256); (𝑛=26)	23 (16~191); (𝑛=32)	27.5 (17~277); (𝑛=73)	NS
Alanine aminotransferase, mediam (range), (units/L)	26.5 (9~235); (𝑛=27)	34 (12~639); (𝑛=32)	29 (9~525); (𝑛=75)	NS
Cholesterol, mean ± SD, (mg/dL)	102.0±26.1; (𝑛=22)	124.8±29.0; (𝑛=29)	136.3±31.8; (𝑛=68)	0.008^†	<0.001^†	0.089
Triglyceride, mean ± SD, (mg/dL)	121.1±51.0; (𝑛=17)	139.8±67.6; (𝑛=30)	124.2±49.1; (𝑛=69)	NS
HDL, mean ± SD, (mg/dL)	21.4±9.5; (𝑛=17)	22.0±13.5; (𝑛=27)	25.0±10.3; (𝑛=62)	NS
LDL, mean ± SD, (mg/dL)	58.2±21.2; (𝑛=17)	73.2±26.2; (𝑛=27)	82.2±28.1; (𝑛=60)	0.071	0.001^†	0.150
Albumin, mean ± SD, (g/dL)	3.4±0.4; (𝑛=15)	3.8±0.5; (𝑛=26)	3.8±0.5; (𝑛=63)	0.026^†	0.015^†	0.925

^†Statistical significance.
CRP: C-reactive protein; HDL: high-density lipoprotein; LDL: low-density lipoprotein; NS: not statistically significant difference between groups; WBC: white blood cell.